Parenteral anticoagulants in the treatment of acute coronary syndrome: what modern clinical guidelines say
Parenteral administration of high (therapeutic) doses of anticoagulants is a mandatory component of the initial treatment of acute coronary syndrome (ACS) unless contraindicated. In ACS, intravenous administration of unfractionated heparin, the use of low molecular weight heparin enoxaparin, selecti...
Saved in:
| Main Author: | I. S. Yavelov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2022-06-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/270 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME
by: E. A. Smirnova, et al.
Published: (2017-01-01) -
Anticoagulation and monitoring in pediatric extracorporeal membrane oxygenation
by: Jamie Weller, et al.
Published: (2018-12-01) -
BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01) -
Anticoagulant therapy in patients with acute coronary syndrome and COVID-19
by: Yu. N. Panina, et al.
Published: (2021-09-01) -
ANTICOAGULANTS IN ACUTE CORONARY SYNDROME
by: I. A. Latfullin, et al.
Published: (2016-01-01)